Vaccines

New Analysis Finds that G7+EU Excess Doses Can Cover 40% Supply Gap in 2021

Fri, 11/26/2021 - 15:01
Andrea Taylor New Analysis Finds that G7+EU Excess Doses Can Cover 40% Supply Gap in 2021 We are excited to announce the release of new analysis and recommendations through our initiative, the COVID Global Accountability Platform (COVID GAP), a collaboration between Duke University and the Covid Collaborative. There are a plethora of dashboards and datasets on COVID-19 response, including vaccine supply and vaccination coverage, providing detail on what is happening both globally and at the country level. However, the existence of these dashboards is not resulting in actions that meet the pressing needs. The COVID GAP pulls together key data across multiple sources to highlight the need and provide evidence-based recommendations to catalyze effective actions and share promising strategies. Our latest report focuses on the 40% and 70% vaccination coverage targets, which have been widely endorsed by global leaders but without any action plan to ensure it happens. Drawing on data from our Launch and Scale Speedometer COVID research, as well as the Multilateral Leaders Task Force on COVID-19, and the WHO, we find that 82 countries (including most low-income and African countries) are not on track to meet 40% vaccination coverage by the end of 2021. At the global level, this is not a supply issue but a distribution issue. The scale up of COVID-19 vaccine production over the past year has been staggeringly successful; the world is now making about 1.5 billion doses a month. We have enough doses to vaccinate far more than 40% of the population in every country. However, much of this supply is concentrated in a small number of wealthy countries, who have more than they can use. Based on supply and vaccination rate data, we expect G7 and EU countries to collectively have more than 830 million excess doses at the end of 2021. Meanwhile, many countries still face significant supply gaps. For the countries that have not yet reached 40% coverage, our analysis indicates that a further 1.05 billion doses are still needed to reach the target. After expected COVAX deliveries in November and December, these countries will still face a gap of 650 million doses. Driven by this analysis, the COVID GAP team urgently recommends that vaccine makers and donor countries: • Improve transparency on vaccine production, supply, and allocation to drive accountability and effective vaccination planning – countries need advance notice of delivery schedules • Allocate increasing supply of vaccines more equitably, through “queue swapping” and fulfilling donation pledges • Strengthen country-level capacity to ensure doses get from airports into arms as quickly and efficiently as possible Future analyses will focus on the quantifying the need and tracking commitments for therapeutics, diagnostics, and oxygen, as well as future preparedness. The COVID GAP team is working closely with leaders in low- and middle-income countries as well as multilateral organizations and major funders to build stronger data on the challenges, bottlenecks, and promising strategies to advance access to COVID-19 vaccines, therapeutics, and other resources around the world. We will continue to update the data and insights on the covid19gap.org website, just as we do for the Launch and Scale Speedometer COVID data and will draw on these analyses to develop practical recommendations. As always, we welcome input on how you are using these analyses and if there are particular areas of focus for our data tracking through Launch and Scale Speedometer or COVID GAP that would be helpful.

What the latest Global COVID-19 Summit achieved (and missed)

Fri, 09/24/2021 - 20:13
As we and a coalition of over 100 leaders and organizations called for, President Biden hosted a Global COVID-19 Summit on Wednesday. With participation of world leaders mostly virtually, the Summit covered familiar ground as well as some new territory.

The World needs more deliveries, not pledges

Sat, 09/18/2021 - 20:18
Deliveries of vaccine donations are more important than ever, given the persistent gaps in vaccine coverage globally and threat of the highly contagious delta variant.

Will Cuba's home-grown vaccine strategy pay off?

Sat, 09/11/2021 - 03:45
Cuba has become the leader of COVID-19 vaccine development in Latin America – producing a total of five vaccine candidates so far, four of which are awaiting submission to WHO’s Emergency Use Listing Procedure (EUL).

We need a better plan.

Fri, 08/27/2021 - 19:13
The past 18 months have shown us what happens when we rely on fragmented responses to a pandemic – the result is an uncoordinated patchwork of insufficient approaches and the continued spread of an ever-mutating virus. It sounds obvious but still needs to be said: pandemics are global and our response must be as well.

Looking into Vaccine Wastage

Fri, 08/13/2021 - 12:53
Despite the shortage of Covid-19 vaccines globally, millions of doses are being wasted rather than used. Vaccine wastage is defined as vaccines discarded, lost, damaged or destroyed according to the WHO.

Will booster shots prolong the pandemic?

Fri, 08/06/2021 - 04:19
A handful of wealthy countries recently announced plans to roll out booster shots in late 2021 for vulnerable populations already fully vaccinated against Covid-19.